We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.26T Turnover 23.45%
1-Year Est. Return 41.03%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+41.03%
3 Year Est. Return
+173.37%
5 Year Est. Return
+166.23%
10 Year Est. Return
+509.07%
AUM
$1.26T
AUM Growth
-$27.4B
Cap. Flow
-$3.98B
Cap. Flow %
-0.32%
Top 10 Hldgs %
26.48%
Holding
15,103
New
1,828
Increased
5,364
Reduced
6,090
Closed
1,713
Avg Time Held Equity + Options
3.9 years
Top 10 Avg Time Held Equity + Options
4.7 years
Top 20 Avg Time Held Equity + Options
5.5 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.6 years
Top 20 Avg Time Held Equity only
3.6 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 94.76%
2 Technology 2.14%
3 Communication Services 0.56%
4 Consumer Discretionary 0.56%
5 Healthcare 0.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
RMM icon
12001
RiverNorth Managed Duration Municipal Income Fund
RMM
$250M
$195K ﹤0.01%
+15,528
New +$220K
2026 Q3
0 quarters
RNAC icon
12002
Cartesian Therapeutics
RNAC
$185M
$195K ﹤0.01%
+27,007
New +$235K
2026 Q3
0 quarters
VLRS icon
12003
CALL
Controladora Vuela Compania de Aviacion
VLRS
$930M
$194K ﹤0.01%
+29,600
New +$220K
2026 Q3
0 quarters
IRWD icon
12004
CALL
Ironwood Pharmaceuticals
IRWD
$803M
$194K ﹤0.01%
48,800
-109,500
-69% -$457K
2025 Q4
3 quarters
SMPL icon
12005
Simply Good Foods
SMPL
$1.1B
$194K ﹤0.01%
20,394
-9,082
-31% -$100K
2026 Q1
2 quarters
CGEN icon
12006
PUT
Compugen
CGEN
$193M
$193K ﹤0.01%
81,300
-43,600
-35% -$106K
2026 Q2
1 quarter
ESCA icon
12007
Escalade
ESCA
$294M
$193K ﹤0.01%
10,167
-9,048
-47% -$180K
2026 Q1
2 quarters
BCSF icon
12008
CALL
Bain Capital Specialty
BCSF
$705M
$193K ﹤0.01%
17,500
-6,100
-26% -$74.1K
2024 Q3
8 quarters
VERX icon
12009
PUT
Vertex
VERX
$2.99B
$193K ﹤0.01%
+16,400
New +$208K
2026 Q3
0 quarters
VANI icon
12010
Vivani Medical
VANI
$92M
$193K ﹤0.01%
155,779
+127,433
+450% +$171K
2024 Q2
9 quarters
EWZS icon
12011
CALL
iShares MSCI Brazil Small-Cap ETF
EWZS
$286M
$193K ﹤0.01%
+14,500
New +$188K
2026 Q3
0 quarters
CHIQ icon
12012
Global X MSCI China Consumer Discretionary ETF
CHIQ
$98.7M
$193K ﹤0.01%
12,232
-87,618
-88% -$1.51M
2025 Q4
3 quarters
OPHC icon
12013
OptimumBank Holdings
OPHC
$136M
$193K ﹤0.01%
22,120
-32,511
-60% -$265K
2025 Q1
6 quarters
HUMA icon
12014
PUT
Humacyte
HUMA
$150M
$193K ﹤0.01%
370,500
-327,300
-47% -$209K
2023 Q3
12 quarters
STEM icon
12015
CALL
Stem
STEM
$19M
$193K ﹤0.01%
45,300
-19,200
-30% -$109K
2020 Q4
23 quarters
VRRM icon
12016
PUT
Verra Mobility
VRRM
$264M
$192K ﹤0.01%
61,900
-57,100
-48% -$241K
2026 Q1
2 quarters
OCSL icon
12017
PUT
Oaktree Specialty Lending
OCSL
$1.06B
$192K ﹤0.01%
16,100
-29,400
-65% -$366K
2023 Q3
12 quarters
DOUG icon
12018
Douglas Elliman
DOUG
$150M
$191K ﹤0.01%
125,814
-18,442
-13% -$33.2K
2021 Q4
19 quarters
FOXF icon
12019
Fox Factory Holding
FOXF
$733M
$191K ﹤0.01%
10,409
-21,506
-67% -$416K
2025 Q4
3 quarters
VIR icon
12020
PUT
Vir Biotechnology
VIR
$1.64B
$191K ﹤0.01%
17,100
-19,700
-54% -$197K
2020 Q1
26 quarters
GNLX icon
12021
Genelux
GNLX
$86.9M
$191K ﹤0.01%
+75,562
New +$206K
2026 Q3
0 quarters
AURA icon
12022
Aura Biosciences
AURA
$751M
$191K ﹤0.01%
+30,401
New +$217K
2026 Q3
0 quarters
MPLT icon
12023
MapLight Therapeutics
MPLT
$383M
$191K ﹤0.01%
+18,698
New +$351K
2026 Q3
0 quarters
EMAT icon
12024
Evolution Metals & Technologies
EMAT
$435M
$191K ﹤0.01%
+74,718
New +$292K
2026 Q3
0 quarters
FIGG icon
12025
Leverage Shares 2x Long FIG Daily ETF
FIGG
$6.6M
$191K ﹤0.01%
+12,380
New +$271K
2026 Q3
0 quarters

Similar funds

Jeff Yass's Q3 2026 Portfolio in Review

As of Q3 2026, Jeff Yass held 15,103 positions worth $1.26T, down 2.1% from $1.28T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Jeff Yass's Q3 2026 filing shows 1,828 new, 5,364 increased, 6,090 reduced and 1,713 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M. The largest sale was Microsoft, an estimated $2.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q3 2026 buy was iShares Core MSCI EAFE ETF: 4,178,565 shares worth $405M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $4.73B increase.
  • Jeff Yass's biggest Q3 2026 reduction was Microsoft, cutting an estimated $2.88B.
  • Jeff Yass fully exited Capital Group Growth ETF in Q3 2026, selling an estimated $279M.
  • Jeff Yass's ten largest holdings make up 26% of its $1.26T portfolio in Q3 2026.
  • Jeff Yass opened 1,828 new positions and closed 1,713 in Q3 2026.
  • Jeff Yass's portfolio value fell 2.1% quarter-over-quarter to $1.26T.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.